Partners

We are collaborating with leading clinicians, manufacturers and Contract Research Organizations in the
upcoming Phase 3 study.

Potential partners interested in co-development and commercialization of Bupizenge®, please contact
CEO Paul de Potocki: paul.de.potocki@oncozenge.se